Ticker Scorecard - FBIO Basics Company: Fortress Biotech, Inc. IPO Date: December 1, 2011 Sector: Healthcare Industry: Biotech Market Cap: $50.38M Activated in VL: True Average Daily Range Avg Daily Range: $0.08 | 3.67% Avg Daily Range (30 D): $0.06 | 3.10% Avg Daily Range (90 D): $0.06 | 3.44% Institutional Daily Volume Avg Daily Volume: .06M Avg Daily Volume (30 D): .48M Avg Daily Volume (90 D): .57M Trade Size Avg Trade Size (Sh.): 34 Avg Trade Size (Sh.) (30 D): 227 Avg Trade Size (Sh.) (90 D): 259 Institutional Trades Total Inst.Trades: 36 Avg Inst. Trade: $2.41M Avg Inst. Trade (30 D): $1.09M Avg Inst. Trade (90 D): $1.09M Avg Inst. Trade Volume: .03M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $3.49M Avg Closing Trade (30 D): $M Avg Closing Trade (90 D): $M Avg Closing Volume: 11.5K     News Jul 10, 2024 @ 12:41 PM Fortress Biotech CEO buys $36.7k in preferred stoc... Source: Investing.Com Jul 8, 2024 @ 7:10 AM Greenbrier, Fortress Biotech And 3 Stocks To Watch... Source: Avi Kapoor Jul 2, 2024 @ 12:00 PM Checkpoint Therapeutics Announces $12 Million Regi... Source: Checkpoint Therapeutics, Inc Jul 2, 2024 @ 11:00 AM Checkpoint Therapeutics Announces Biologics Licens... Source: Checkpoint Therapeutics, Inc Jun 24, 2024 @ 11:30 AM Checkpoint Therapeutics Announces Alignment with F... Source: Checkpoint Therapeutics, Inc Financials   TTM Q2 2024 Q1 2024 Basic EPS $-.76 $-.73 $-1.03 Diluted EPS $-.76 $-.73 $-1.03 Revenue $ 14.63M $ 14.9M $ 13.03M Gross Profit $ 9.34M $ 8.36M $ 6.21M Net Income / Loss $ -26.69M $ -28.82M $ -39.02M Operating Income / Loss $ -22.1M $ -27.79M $ -36.57M Cost of Revenue $ 5.29M $ 6.54M $ 6.82M Net Cash Flow $ M $ M $ M PE Ratio     Splits Oct 10, 2023:   15:1 Dec 06, 2022:   10:1